{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:09:56Z","timestamp":1792789796003,"version":"4.5.0"},"reference-count":39,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Imperial Open Access"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Neonatal respiratory distress syndrome (NRDS), resulting from a deficiency of pulmonary surfactant (PS), can cause alveoli to collapse. Glucocorticoids reduce inflammation and are effective in reducing pulmonary swelling. This study aims to assess the effectiveness of the combination of PS and budesonide in the management of NRDS. Materials and Methods: Publications between 21 May and 24 November were screened through PubMed, Cochrane and Embase. Data analysis was performed on RevMan 5.3 software. Subgroup analysis was performed to evaluate the routes of administrations. Results: The use of budesonide along with pulmonary surfactant for treating NRDS revealed the following results: (1) a reduced duration of invasive mechanical ventilation (standardized mean difference (SMD) = \u22121.06, 95% confidence interval (CI) = \u22121.55 to \u22120.56, p &lt; 0.0001); (2) reduced rate of bronchopulmonary dysplasia (BPD) occurrence (relative risk (RR) = 0.72, 95% CI = 0.60 to 0.86, p = 0.0003); (3) reduced duration for hospital admittance (SMD = \u22120.38, 95% CI = \u22120.64 to \u22120.11, p = 0.005). The occurrence of complications, i.e., sepsis, pneumothorax, retinopathy of prematurity (ROP), necrotizing enterocolitis (NEC), rate of mortality, hyperglycemia and intraventricular hemorrhage (IVH), was not significantly different among the intervention and comparison group except for patent ductus arteriosus (PDA) and pulmonary hemorrhage, with their incidence being higher in the control group (p = 0.002 and p = 0.05, respectively). Conclusions: The combination of pulmonary surfactant and budesonide decreases the occurrence of BPD, duration of mechanical ventilation, length of hospital stay and risk of pulmonary hemorrhage and PDA. It does not increase the risk of complications and death and is clinically safe.<\/jats:p>","DOI":"10.3390\/medicina61081329","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T14:22:44Z","timestamp":1753280564000},"page":"1329","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative Efficacy and Safety Profile of the Combination of Pulmonary Surfactant and Budesonide vs. Surfactant Alone in the Management of Neonatal Respiratory Distress Syndrome: An Updated Meta-Analysis"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3179-9682","authenticated-orcid":false,"given":"Urooj","family":"Fatima","sequence":"first","affiliation":[{"name":"Department of Medicine, Services Institute of Medical Science (SIMS), Lahore 54000, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0251-2830","authenticated-orcid":false,"given":"Naveera","family":"Naveed","sequence":"additional","affiliation":[{"name":"Department of Radiology, Shahida Islam Medical College, Bahawalpur 60600, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8208-9914","authenticated-orcid":false,"given":"Zahra","family":"Riaz","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sargodha Medical College, Sargodha 40100, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0584-6907","authenticated-orcid":false,"given":"Emaan","family":"Khalid","sequence":"additional","affiliation":[{"name":"Department of Medicine, Services Institute of Medical Science (SIMS), Lahore 54000, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0106-0476","authenticated-orcid":false,"given":"Aemon","family":"Qamer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Karachi Medical and Dental College, Karachi 74700, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3653-6007","authenticated-orcid":false,"given":"Shehmeen","family":"Baig","sequence":"additional","affiliation":[{"name":"Department of Medicine, Karachi Medical and Dental College, Karachi 74700, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0825-0828","authenticated-orcid":false,"given":"Roshaan","family":"Fatima","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sargodha Medical College, Sargodha 40100, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6907-510X","authenticated-orcid":false,"given":"Asawir","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Medicine, Allama Iqbal Medical College, Lahore 54550, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoya","family":"Mustunsar","sequence":"additional","affiliation":[{"name":"Department of Medicine, University College of Medicine and Dentistry (The University of Lahore), Lahore 54600, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Sciences, Karachi 74200, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Mangan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ziauddin Medical College, Karachi 75600, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5152-9178","authenticated-orcid":false,"given":"Mehak","family":"Kumari","sequence":"additional","affiliation":[{"name":"Department of Medicine, Liaquat University of Medical and Health Sciences, Shahdadpur 76090, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soban","family":"Ali Qasim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Multan Medical and Dental College, Multan 59300, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hasan","sequence":"additional","affiliation":[{"name":"Department of Medicine, National heart and Lung Institute, Imperial College London, London SW7 2AZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raheel","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Medicine, National heart and Lung Institute, Imperial College London, London SW7 2AZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.pedneo.2022.02.002","article-title":"New developments in neonatal respiratory management","volume":"63","author":"Chen","year":"2022","journal-title":"Pediatr. Neonatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1891\/0730-0832.34.4.231","article-title":"Respiratory Development and Respiratory Distress Syndrome","volume":"34","author":"Rubarth","year":"2015","journal-title":"Neonatal Netw."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"C798","DOI":"10.1152\/ajpcell.00337.2024","article-title":"Factors influencing airway smooth muscle tone: A comprehensive review with a special emphasis on pulmonary surfactant","volume":"327","author":"Hanusrichterova","year":"2024","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/1574884714666191007154936","article-title":"Prenatal Administration of Betamethasone and Neonatal Respiratory Distress Syndrome in Multifetal Pregnancies: A Randomized Controlled Trial","volume":"15","author":"Abbasalizadeh","year":"2020","journal-title":"Curr. Clin. Pharmacol."},{"key":"ref_5","first-page":"12","article-title":"Neonatal Respiratory Distress Syndrome: Tackling A Worldwide Problem","volume":"44","author":"Dyer","year":"2019","journal-title":"Pharm. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Najafian, B., and Hossein Khosravi, M. (2020). Neonatal Respiratory Distress Syndrome: Things to Consider and Ways to Manage [Internet]. Update on Critical Issues on Infant and Neonatal Care, IntechOpen.","DOI":"10.5772\/intechopen.90885"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1080\/10717544.2019.1618418","article-title":"Biophysical and chemical stability of surfactant\/budesonide and the pulmonary distribution following intra-tracheal administration","volume":"26","author":"Chen","year":"2019","journal-title":"Drug Deliv."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pedneo.2014.04.009","article-title":"Effect of surfactant and budesonide on the pulmonary distribution of fluorescent dye in mice","volume":"56","author":"Huang","year":"2015","journal-title":"Pediatr. Neonatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s13063-023-07257-5","article-title":"Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: Study protocol for the international, multicenter, randomized PLUSS trial","volume":"24","author":"Manley","year":"2023","journal-title":"Trials"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/s41390-019-0663-6","article-title":"Surfactant and budesonide for respiratory distress syndrome: An observational study","volume":"87","author":"Kothe","year":"2020","journal-title":"Pediatr. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1164\/rccm.201505-0861OC","article-title":"Intratracheal Administration of Budesonide\/Surfactant to Prevent Bronchopulmonary Dysplasia","volume":"193","author":"Yeh","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-3659(99)00230-8","article-title":"Drug solubilization in lung surfactant","volume":"65","author":"Wiedmann","year":"2000","journal-title":"J. Control. Release"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.34172\/aim.31725","article-title":"Endotracheal Surfactant and Budesonide Combination Therapy in Neonatal Acute Respiratory Distress Syndrome due to Late-Onset Sepsis","volume":"27","author":"Gunes","year":"2024","journal-title":"Arch. Iran. Med."},{"key":"ref_14","unstructured":"Lee, M.J., Gunn, D., and Antenatal Corticosteroid Therapy for Reduction of Neonatal Morbidity and Mortality from Preterm Delivery (2015, February 23). UpToDate Web Site. Available online: https:\/\/www.uptodate.com\/contents\/antenatal-corticosteroid-therapy-for-reduction-of-neonatal-respiratory-morbidity-and-mortality-from-preterm-delivery."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000528914","article-title":"European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update","volume":"120","author":"Sweet","year":"2023","journal-title":"Neonatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomized trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref_17","unstructured":"Chen, S.Q. (2019). Clinical Study of Budesonide Combined with Pulmonary Surfactant in the Treatment of Neonatal Respiratory Distress Syndrome, Guangdong Medical University."},{"key":"ref_18","first-page":"33","article-title":"Pulmonary surfactant in combination with intratracheal budesonide instillation for treatment of respiratory distress syndrome in preterm infants: A randomized controlled trial","volume":"36","author":"Yang","year":"2021","journal-title":"Chin. J. Neonatol."},{"key":"ref_19","first-page":"137","article-title":"Clinical efficacy of pulmonary surfactant combined with budesonide for preventing bronchopulmonary dysplasia in very low birth weight infants","volume":"19","author":"Pan","year":"2017","journal-title":"Chin. J. Contemp. Pediatr."},{"key":"ref_20","first-page":"97","article-title":"Efficacy of intratracheal instillation of budesonide using surfactant as a vehicle to treatment respiratory distress syndrome of preterm infants","volume":"46","author":"Deng","year":"2018","journal-title":"Med. Sci. J. Cent. S. China"},{"key":"ref_21","first-page":"61","article-title":"The clinical study of budesonide combined with pulmonary surfactant to prevent bronchopulmonary dysplasia in premature infants","volume":"46","author":"Su","year":"2019","journal-title":"Int. J. Pediatr."},{"key":"ref_22","first-page":"27","article-title":"Effects of Budesonide Combined with Pulmonary Surfactant on ShortTerm Efficacy, Blood Oxygenation Index and Risk of Bronchopulmonary Dysplasia in Premature Infants with Severe Respiratory Distress Syndrome","volume":"25","author":"Zhou","year":"2019","journal-title":"J. Pediatr. Pharm."},{"key":"ref_23","first-page":"154","article-title":"The effect of dual bronchial drug infusion program on the clinical prognosis of preterm infants with severe respiratory distress syndrome","volume":"42","author":"Ping","year":"2019","journal-title":"Chin. J. Postgrad. Med."},{"key":"ref_24","first-page":"1243","article-title":"Effect of budesonide inhalation combined with pulmonary surfactant on newborns with RDS","volume":"46","author":"Wang","year":"2018","journal-title":"Mod. Med. J."},{"key":"ref_25","first-page":"2121","article-title":"Effect of Budesonide suspension oxygenation atomization inhalation on prevention and treatment of bronchopulmonary dysplasia in premature infants","volume":"19","author":"Wang","year":"2019","journal-title":"J. Clin. Exp. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/jcn.jcn_52_23","article-title":"Budesonide and surfactant combination for treatment of respiratory distress syndrome in preterm neonates and evaluation outcomes","volume":"12","author":"Safa","year":"2023","journal-title":"J. Clin. Neonatol."},{"key":"ref_27","first-page":"1","article-title":"Intratracheal administration of budesonide-instilled surfactant for prevention of bronchopulmonary dysplasia: A randomized controlled clinical trial","volume":"14","author":"Armanian","year":"2023","journal-title":"Iran. J. Neonatol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Marzban, A., Mokhtari, S., Tavakkolian, P., Mansouri, R., Jafari, N., and Maleki, A. (2024). The impact of combined administration of surfactant and intratracheal budesonide compared to surfactant alone on bronchopulmonary dysplasia (BPD) and mortality rate in preterm infants with respiratory distress syndrome: A single-blind randomized clinical trial. BMC Pediatr., 24.","DOI":"10.1186\/s12887-024-04736-9"},{"key":"ref_29","first-page":"78","article-title":"Efficacy and safety of intratracheal administration of budesonide combined with pulmonary surfactant in preventing bronchopulmonary dysplasia: A prospective randomized controlled trial","volume":"24","author":"Liu","year":"2022","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.5001\/omj.2021.84","article-title":"A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia","volume":"36","author":"Gharehbaghi","year":"2021","journal-title":"Oman Med. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"526","DOI":"10.21037\/tp-22-8","article-title":"A systematic review and meta-analysis of pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome","volume":"11","author":"Yi","year":"2022","journal-title":"Transl. Pediatr."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Meng, S.S., Chang, W., Lu, Z.H., Xie, J.F., Qiu, H.B., Yang, Y., and Guo, F.M. (2019). Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: A meta-analysis of randomized controlled trials. BMC Pulm. Med., 19.","DOI":"10.1186\/s12890-018-0761-y"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1165\/rcmb.2016-0068OC","article-title":"Antiinflammatory Effects of Budesonide in Human Fetal Lung","volume":"55","author":"Barrette","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/jrms.JRMS_106_19","article-title":"The efficacy of intratracheal administration of surfactant and budesonide combination in the prevention of bronchopulmonary dysplasia","volume":"26","author":"Gharehbaghi","year":"2021","journal-title":"J. Res. Med. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e1310","DOI":"10.1542\/peds.2007-1973","article-title":"Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: A pilot study","volume":"121","author":"Yeh","year":"2008","journal-title":"Pediatrics"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/ppul.23680","article-title":"Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis","volume":"52","author":"Venkataraman","year":"2017","journal-title":"Pediatr. Pulmonol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ppul.25759","article-title":"Effectiveness and safety of early combined utilization of budesonide and surfactant by airway for bronchopulmonary dysplasia prevention in premature infants with RDS: A meta-analysis","volume":"57","author":"Tang","year":"2022","journal-title":"Pediatr. Pulmonol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJMoa1708831","article-title":"Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia","volume":"378","author":"Bassler","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1329\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:14:47Z","timestamp":1760033687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["medicina61081329"],"URL":"https:\/\/doi.org\/10.3390\/medicina61081329","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]}}}